keyword
https://read.qxmd.com/read/38758481/probiotic-pediococcus-acidilactici-strains-exert-anti-inflammatory-effects-by-regulating-intracellular-signaling-pathways-in-lps-induced-raw-264-7-cells
#61
JOURNAL ARTICLE
Im-Kyung Woo, Jun-Hyun Hyun, Hye Ji Jang, Na-Kyoung Lee, Hyun-Dong Paik
This study investigated the anti-inflammatory effects of Pediococcus acidilactici strains isolated from fermented vegetables on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. In addition, the probiotic characteristics and safety were evaluated. Our results show that Ped. acidilactici strains possess high survivability in simulated gastrointestinal environments and strong attachment to HT-29 cells. All Ped. acidilactici strains exhibited γ-hemolysis and resistance to gentamicin, kanamycin, and streptomycin, a characteristic commonly observed in lactic acid bacteria...
May 17, 2024: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/38758472/mitophagy-in-health-and-disease-molecular-mechanisms-regulatory-pathways-and-therapeutic-implications
#62
REVIEW
Mark S D'Arcy
Mitophagy, a specialised form of autophagy, selectively targeting damaged or dysfunctional mitochondria, and is crucial for maintaining cellular homeostasis and mitochondrial quality control. Dysregulation of mitophagy contributes to various pathological conditions, including cancer, neurodegenerative and cardiovascular diseases. This review presents a comprehensive analysis of the molecular mechanisms, regulatory pathways, and interplay with other cellular processes governing mitophagy, emphasizing its importance in physiological and pathological contexts...
May 17, 2024: Apoptosis: An International Journal on Programmed Cell Death
https://read.qxmd.com/read/38758462/translational-utility-of-organoid-models-for-biomedical-research-on-gastrointestinal-diseases
#63
REVIEW
Pratibha Banerjee, Sabyasachi Senapati
Organoid models have recently been utilized to study 3D human-derived tissue systems to uncover tissue architecture and adult stem cell biology. Patient-derived organoids unambiguously provide the most suitable in vitro system to study disease biology with the actual genetic background. With the advent of much improved and innovative approaches, patient-derived organoids can potentially be used in regenerative medicine. Various human tissues were explored to develop organoids due to their multifold advantage over the conventional in vitro cell line culture approach and in vivo models...
May 17, 2024: Stem cell reviews and reports
https://read.qxmd.com/read/38758435/mitochondria-targeted-esculetin-administration-improves-insulin-resistance-and-hyperglycemia-induced-atherosclerosis-in-db-db-mice
#64
JOURNAL ARTICLE
Gajalakshmi Singuru, Sriravali Pulipaka, Altab Shaikh, Shashikanta Sahoo, Aruna Jangam, Rajamannar Thennati, Srigiridhar Kotamraju
The development and progression of hyperglycemia (HG) and HG-associated atherosclerosis are exacerbated by mitochondrial dysfunction due to dysregulated mitochondria-derived ROS generation. We recently synthesized a novel mitochondria-targeted esculetin (Mito-Esc) and tested its dose-response therapeutic efficacy in mitigating HG-induced atherosclerosis in db/db mice. In comparison to simvastatin and pioglitazone, Mito-Esc administration resulted in a considerable reduction in body weights and improved glucose homeostasis, possibly by reducing hepatic gluconeogenesis, as indicated by a reduction in glycogen content, non-esterified free fatty acids (NEFA) levels, and fructose 1,6-bisphosphatase (FBPase) activity...
May 17, 2024: Journal of Molecular Medicine: Official Organ of the "Gesellschaft Deutscher Naturforscher und Ärzte"
https://read.qxmd.com/read/38758406/screening-for-ferroptosis-genes-related-to-endometrial-carcinoma-and-predicting-of-targeted-drugs-based-on-bioinformatics
#65
JOURNAL ARTICLE
Rui Wang, Wei Lang, Qian Xue, Le Zhang, Yunzhu Xujia, Chaofan Wang, Xin Fang, Shidi Gao, Li Guo
Endometrial carcinoma is one of most common malignant tumors in women, and ferroptosis is closely related to the development and treatment of endometrial carcinoma. The aim of this study was to screen ferroptosis-related genes associated with endometrial carcinoma and predict targeted drugs through bioinformatics. 761 differentially expressed genes were obtained by the dataset GSE63678 from the GEO database, and most of the genes were enriched in the KEGG_CELL_CYCLE and KEGG_OOCYTE_MEIOSIS signaling pathways...
May 17, 2024: Archives of Toxicology
https://read.qxmd.com/read/38758385/assessing-clinical-pathological-characteristics-and-gene-expression-patterns-associated-with-hepatoid-adenocarcinoma-of-the-stomach
#66
JOURNAL ARTICLE
Dong-Feng Ge, Yang-Kun Wang, Ying-Ying Li, Xing-Hai Liao, Chao-Ya Zhu, Bo Jiang, Su-Nan Wang
OBJECTIVE: The objective of this study is to assess the clinical pathological attributes of Hepatoid Adenocarcinoma of the Stomach (HAS) and to delineate the differential diagnostic considerations about it. METHOD: The investigation involved analyzing 31 HAS cases using histomorphological assessment, immunohistochemical profiling, and relevant gene detection methodologies. RESULTS: Among the 31 HAS cases, 9 (29.0%) were of trabecular hepatoid adenocarcinoma of the stomach, 7 (22...
May 17, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38758372/the-later-line-efficacy-and-safety-of-immune-checkpoint-inhibitors-plus-anlotinib-in-egfr-mutant-patients-with-egfr-tki-resistant-nsclc-a-single-center-retrospective-study
#67
JOURNAL ARTICLE
Xiaoyan Yin, Xinchao Liu, Fei Ren, Xiangjiao Meng
BACKGROUND: Effective treatment after EGFR-TKI resistance is of great clinical concern. We aimed to investigate the efficacy and safety of anlotinib in combination with an anti-PD-1/PD-L1 antibody in later-line therapy for EGFR-mutant NSCLC patients after TKI treatment failure and to explore the independent predictive factors of therapeutic efficacy. METHODS: A total of 71 patients with confirmed advanced EGFR-mutated NSCLC who progressed after previous standard EGFR-TKI therapy but still failed after multiline treatments were included retrospectively in this study...
May 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38758356/inflammation-and-huntington-s-disease-a-neglected-therapeutic-target
#68
REVIEW
Sophie E Field, Annabel J Curle, Roger A Barker
INTRODUCTION: Huntington's Disease (HD) is a genetic neurodegenerative disease for which there is currently no disease-modifying treatment. One of several underlying mechanisms proposed to be involved in HD pathogenesis is inflammation; there is now accumulating evidence that the immune system may play an integral role in disease pathology and progression. As such, modulation of the immune system could be a potential therapeutic target for HD. AREAS COVERED: To date, the number of trials targeting immune aspects of HD has been limited...
May 17, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38758346/evolution-and-global-research-trends-of-immunity-in-diabetic-nephropathy-a-bibliometric-and-visual-analysis-from-2004-to-2023
#69
JOURNAL ARTICLE
Jianlong Zhou, Lv Zhu, Rensong Yue
BACKGROUND: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with an increasing prevalence worldwide, but its pathomechanisms remain incompletely understood. Accumulating evidence suggests that immunity plays an important role in the development of DN. Many papers have been published in the field over the last 20 years, but there has been no bibliometric review of the research hotspots and trends in the field. This study aimed to assess the current research status and future trends of the link between immune and DN using bibliometric analysis...
May 17, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38758334/vaccine-strategies-for-cryptococcus-neoformans
#70
JOURNAL ARTICLE
Veronica Soares Brauer, Samyr Machado Querobino, Gabriel Soares Matos, Deveney Dasilva, Maurizio Del Poeta
Cryptococcus neoformans infections are a major worldwide concern as current treatment strategies are becoming less effective in alleviating the infection. The most extreme and fatal cases are those of immunocompromised individuals. Clinical treatments for cryptococcosis are limited to a few classes of approved drugs, and due to a rise in drug resistance, these drugs are becoming less effective. Therefore, it is essential to develop innovative ways to control this infection. Vaccinations have emerged as a safe, viable, and cost-effective solution to treat a number of diseases over the years...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38758326/antibody-isolation-in-c-neoformans
#71
JOURNAL ARTICLE
Susana Ruiz Mendoza, Marina da Silva Ferreira, Michele Ramos Valente, Allan Jefferson Guimarães
The importance of humoral immunity to fungal infections remains to be elucidated. In cryptococcosis, patients that fail to generate antibodies against antigens of the fungus Cryptococcus neoformans are more susceptible to the disease, demonstrating the importance of these molecules to the antifungal immune response. Historically, antibodies against C. neoformans have been applied in diagnosis, therapeutics, and as important research tools to elucidate fungal biology. Throughout the process of generating monoclonal antibodies (mAbs) from a single B-cell clone and targeting a single epitope, several immunization steps might be required for the detection of responsive antibodies to the antigen of interest in the serum...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38758308/the-rabbit-model-of-cryptococcal-meningitis
#72
JOURNAL ARTICLE
Charles Giamberardino, John R Perfect
Cryptococcal meningitis (CM) is a fungal disease caused by the invasion of Cryptococcus yeast cells into the central nervous system. The organism is thought to enter the body through the lungs and then escape due to dysregulation of the immune response. Multiple animal species have been used to model the infection and characterize CM including mice, rats, dogs, guinea pigs, and rabbits. The rabbit model has over 40 years of data and has been used to study host-pathogen interactions and the efficacy of antifungal therapeutics...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38758295/french-guidelines-on-tips-indications-and-modalities
#73
REVIEW
Hélène Larrue, Manon Allaire, Delphine Weil-Verhoeven, Sandrine Barge, Dominique Thabut, Audrey Payance, Lucile Moga, Caroline Jézéquel, Florent Artru, Isabelle Archambeaud, Laure Elkrief, Frédéric Oberti, Charles Roux, Wim Laleman, Marika Rudler, Sébastien Dharancy, Nolwenn Laborde, Anne Minello, Thomas Mouillot, Elvire Desjonquères, Line Caroll Ntandja Wandji, Marc Bourlière, Nathalie Ganne-Carrié, Christophe Bureau
Transjugular intrahepatic portosystemic shunt (TIPS) has become essential in the treatment or prevention of portal hypertension-related complications. In the early 1990s, the primary indication was refractory bleeding. It is now proposed for the treatment of ascites for the prevention of bleeding and in patients with vascular diseases of the liver. Thus, there are a growing number of patients being treated with TIPS all over the world. The broadening of indications, the involvement of multiple stakeholders, the need for an accurate selection, the positioning in relation to transplantation and the lack of standardization in pre-therapeutic assessment, in the procedure itself and in the follow-up have led the board of the French Association for the Study of the Liver to establish recommendations...
May 17, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38758291/estimating-and-rewarding-the-value-of-healthcare-interventions-beyond-the-healthcare-sector-a-conceptual-framework
#74
JOURNAL ARTICLE
Askal Ayalew Ali, Amit Kulkarni, Sandipan Bhattacharjee, Vakaramoko Diaby
BACKGROUND: Evaluating healthcare interventions for their impacts beyond health outcomes may result in recognition of changes in human capital, income level, tax revenue, and government spending, which could affect economic growth and population health. In this paper, we document instances where current health technology assessment (HTA) practices fail to account for the impacts of healthcare interventions on broader society beyond the healthcare sector. METHODS: We propose a novel conceptual framework, highlighting its three components (distributional cost-effectiveness analysis [DCEA], input-output model, and voting scheme) and their contributions to capturing the economic and societal ripple effects of healthcare interventions...
May 17, 2024: PharmacoEconomics
https://read.qxmd.com/read/38758284/integrated-proteomic-and-genomic-analysis-to-identify-predictive-biomarkers-for-valproate-response-in-bipolar-disorder-a-6-month-follow-up-study
#75
JOURNAL ARTICLE
Hyunju Lee, Dohyun Han, Kyung Sue Hong, Kyooseob Ha, Hyeyoon Kim, Eun Young Cho, Woojae Myung, Sang Jin Rhee, Jayoun Kim, Tae Hyon Ha, Kang Eun Lee, Hye Won Jung, Yejin Lee, Dongbin Lee, Hyeona Yu, Daseul Lee, Yun Seong Park, Yong Min Ahn, Ji Hyun Baek, Se Hyun Kim
BACKGROUND: Several genetic studies have been undertaken to elucidate the intricate interplay between genetics and drug responses in bipolar disorder (BD). However, there has been notably limited research on biomarkers specifically linked to valproate, with only a few studies investigating integrated proteomic and genomic factors in response to valproate treatment. Therefore, this study aimed to identify biological markers for the therapeutic response to valproate treatment in BD. Patients with BD in remission were assessed only at baseline, whereas those experiencing acute mood episodes were evaluated at three points (baseline, 8 ± 2 weeks, and 6 ± 1 months)...
May 17, 2024: International Journal of Bipolar Disorders
https://read.qxmd.com/read/38758239/the-lymphocyte-monocyte-ratio-predicts-the-efficacy-of-isatuximab-plus-pomalidomide-in-multiple-myeloma-patients
#76
JOURNAL ARTICLE
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, Yoko Adachi, Naoyuki Anzai, Masaaki Hotta, Kentaro Fukushima, Hideo Yagi, Satoshi Yoshihara, Yasuhiro Tanaka, Teruhito Takakuwa, Hirokazu Tanaka, Hirohiko Shibayama, Nobuhiko Uoshima, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino
BACKGROUND: Isatuximab, an anti-CD38 antibody, has been widely used in treatments for patients with relapsed/refractory multiple myeloma (MM). Despite its high efficacy, not all patients achieve a lasting therapeutic response with isatuximab. OBJECTIVE: We tried to identify biomarkers to predict the effectiveness of isatuximab by focusing on the host's immune status before treatment. METHODS: We retrospectively analyzed the cases of 134 relapsed/refractory MM patients in the Kansai Myeloma Forum database who had received only a first isatuximab treatment...
May 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38758225/potential-therapeutic-effects-of-crocin
#77
REVIEW
Laleh Pourmousavi, Rasoul Hashemkandi Asadi, Farzad Zehsaz, Roghayeh Pouzesh Jadidi
Crocin, a natural bioactive compound derived from saffron (Crocus sativus) and other Crocus genera, has gained significant attention recently due to its potential therapeutic properties. The multifaceted nature of crocin's biological effects has piqued the interest of researchers and health enthusiasts, prompting further investigations into its mechanisms of action and therapeutic applications. This review article comprehensively explores the emerging evidence supporting crocin's role as a promising ally in protecting against metabolic disorders...
May 17, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38758213/expert-panel-recommendations-for-a-standardized-ambulatory-glucose-profile-report-for-connected-insulin-pens
#78
JOURNAL ARTICLE
Gregg D Simonson, Amy Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary, Sylvia Franc, Dana Gershenoff, George Grunberger, Irl B Hirsch, Diana Isaacs, Mary Johnson, David Kerr, Davida Kruger, Chantal Mathieu, Thomas Martens, Revital Nimri, Sean Oser, Anne Peters, Ruth S Weinstock, Eugene E Wright, Carol H Wysham, Richard M Bergenstal
BACKGROUND: Connected insulin pens capture data on insulin dosing/timing and can integrate with continuous glucose monitoring (CGM) devices with essential insulin and glucose metrics into a single platform. Standardization of connected insulin pen reports is desirable to enhance clinical utility with a single report. METHODS: An international expert panel was convened to develop a standardized connected insulin pen report incorporating insulin and glucose metrics into a single, clinically useful report...
May 17, 2024: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/38758212/psychometric-properties-of-the-automated-insulin-delivery-benefits-and-burdens-scale-aid-bbs-for-adults-with-type-1-diabetes
#79
JOURNAL ARTICLE
Jenna B Shapiro, Anthony T Vesco, Michael S Carroll, Jill Weissberg-Benchell
OBJECTIVE: To evaluate the psychometric properties of a patient-reported outcome measure, The Automated Insulin Delivery - Benefits and Burdens Scale (AID-BBS), which was designed to assess benefits and burdens of AID use in adults with type 1 diabetes (T1D). The measure was hypothesized to have validity, reliability, and clinical utility for predicting likelihood of continued use of an AID system. RESEARCH DESIGN AND METHODS: 217 adults with T1D (ages 18 to 82 years) who were enrolled in an AID system research trial completed AID-BBS items at study midpoint (6 weeks) and at the end of the trial (13 weeks)...
May 17, 2024: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/38758211/performance-of-subcutaneous-continuous-glucose-monitoring-in-adult-critically-ill-patients-receiving-vasopressor-therapy
#80
JOURNAL ARTICLE
Ola Friman, Navid Soltani, Marcus Lind, Pia Zetterqvist, Anca Balintescu, Anders Perner, Anders Oldner, Olav Rooyackers, Johan Mårtensson
Background Subcutaneous continuous glucose monitoring (CGM) may facilitate glucose control in the ICU. We aimed to assess the accuracy of CGM (Dexcom G6) against arterial blood glucose (ABG) in adult critically ill patients receiving intravenous insulin infusion and vasopressor therapy. We also aimed to assess feasibility and tolerability of CGM in this setting. Methods We included ICU patients receiving mechanical ventilation, insulin, and vasopressor therapy. Numerical accuracy was assessed by the mean absolute relative difference (MARD), overall, across arterial glucose strata, over different noradrenaline equivalent infusion rates, and over time since CGM start...
May 17, 2024: Diabetes Technology & Therapeutics
keyword
keyword
1248
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.